Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Varenicline in Autism: Theory and Case Report of Clinical and Biochemical Changes.

Journal of child and adolescent psychopharmacology - 1 Nov 2016

Mostafavi Mojdeh, Hardy Paul, Arnold L Eugene

Abstract excerpt

OBJECTIVE: To explore the potential benefits of varenicline (CHANTIX®), a highly specific partial agonist of neuronal α4β2 nicotinic acetylcholine receptors (nAChR), for autistic symptoms, and present resulting biochemical changes in light of dopamine-related genotype. METHODS: The clinical and biochemical changes exhibited by a 19-year-old severely autistic man following the use of low-dose varenicline in an ABA...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Autistic Disorder
Share to Dopamine
Share to Dose-Response Relationship, Drug

Methodology Data sources Editorial policy Privacy Delete account & data About Contact Helena Bioinformatics

Share to DRD1 gene

Share to Genotype

Share to Nicotinic Agonists

Share to Receptors, Nicotinic

Share to Young Adult

Source

Identifiers

PMID: 27123827
DOI: 10.1089/cap.2015.0230

Genes

DRD1

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-08.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Varenicline in Autism: Theory and Case Report of Clinical and Biochemical Changes.PMID 27123827Read ↗

Analysis of neurotransmitters validates the importance of the dopaminergic system in autism spectrum disorder.Semantic proximity Read ↗

The pathophysiology and treatment of autism.Semantic proximity Read ↗

Biogenic Amine Metabolism and Its Genetic Variations in Autism Spectrum Disorder: A Comprehensive Overview.Semantic proximity Read ↗

The α7 nicotinic acetylcholine receptor: A mediator of pathogenesis and therapeutic target in autism spectrum disorders and Down syndrome.Semantic proximity Read ↗

Single nucleotide variations encoding missense mutations in G protein-coupled receptors may contribute to autism.Semantic proximity Read ↗

Genetic variants of neurotransmitter-related genes and miRNAs in Egyptian autistic patients.Semantic proximity Read ↗

Autism in Phenylketonuria Patients: From Clinical Presentation to Molecular Defects.Semantic proximity Read ↗

Chronic sodium bromide treatment relieves autistic-like behavioral deficits in three mouse models of autismSemantic proximity Read ↗

Bridging the translational neuroscience gap: Development of the ‘shiftability’ paradigm and an exemplar protocol to capture psilocybin-elicited ‘shift’ in neurobiological mechanisms in autismSemantic proximity Read ↗

Systematic review of randomized clinical trials testing a pharmacological treatment in adults with autism spectrum disorderSemantic proximity Read ↗

5-HT2A receptor gene polymorphisms in Croatian subjects with autistic disorder.Semantic proximity Read ↗

Diagnosis and treatment of neurotransmitter-related disorders.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.